Deals, Partnering

Collaboration and licensing agreement for genomic-based diagnostic biomarker

Posted on 17 September 2014

Tags: ,

NuView Life Sciences announced entry into an exclusive global licensing and collaboration agreement with Otsuka Pharmaceutical to further develop and commercialize NuView's investigative genomic-based diagnostic biomarker to detect cancers of the breast and prostate.

The agreement also includes all other future diagnostic-imaging applications.

NuView retains all rights for the VPAC1 compound for in-vivo therapeutic delivery and in-vitro urine screen applications.

Otsuka will provide funding for all future clinical trials and commercialization of the VPAC1 biomarker worldwide.

Otsuka intends to utilize NuView's manufacturing subsidiary, US Radiopharmaceuticals to meet requirements for clinical trials through future commercialization upon approval. The two companies anticipate initiating a Phase I trial in the U.S. in the coming months. The VPAC1 biomarker originated at Thomas Jefferson University (TJU) Philadelphia, PA.


Report: Biomarker Partnering Terms and Agreements

Browse: Complete Current Partnering report catalog

View: M&A Scorecard in CP Insight– view top life science partnering deals by value

View: DealMetrics in CP Insight – the latest deal trend infographics for life science deal making

View: CP Insight’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: CP Insight’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter


Print Friendly, PDF & Email

Leave a Reply